Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant.

HYDERABAD -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for a double-digit share in its core U.S. market for its new launches ...

Biocon in its Environmental, Social and Governance (ESG) scores as assessed by S&P Global’s Corporate Sustainability Assessment (CSA) for 2024 has achieved an improvement to 69 in 2024, up 6 points ...

International brokerage Jefferies has upgraded its rating on drugmaker Biocon to 'hold' citing positive newsflow around the regulatory approval of its Bengaluru manufacturing unit. Building on the ...

The pro-localisation policy in the US will not impact Biocon Biologics’ revenue, noted Shreehas Tambe, CEO of Biocon Biologics. The US, which contributes 40 per cent of the company’s revenue ...

The brokerage's optimism stems from an expected operational turnaround for Biocon, driven by key biosimilar launches and a recovery in generics sales. HSBC highlighted several factors that could ...